Tamer M. Fouad

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

John V. Heymach, David H. Harpole, Tetsuya Mitsudomi et al. · New England Journal of Medicine · 2023 · 682 citations · Full text

Medicine, Oncology, Perioperative Medicine +17

Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes

Hiroko Masuda, Takae Brewer, D.D. Liu et al. · Annals of Oncology · 2013 · 140 citations · Full text

Medicine, Cancer Biology, Oncology +16

Design and Rationale for a Phase III, Double-Blind, Placebo-Controlled Study of Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab for the Treatment of Patients With Resectable Stages II and III non-small-cell Lung Cancer: The AEGEAN Trial

John V. Heymach, Tetsuya Mitsudomi, David H. Harpole et al. · Clinical Lung Cancer · 2021 · 109 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis

Tamer M. Fouad, Takahiro Kogawa, Diane D. Liu et al. · Breast Cancer Research and Treatment · 2015 · 95 citations · Full text

Medicine, Oncology, Surgery +16

Does optical coherence tomography identify arterial healing after stenting? An in vivo comparison with histology, in a rabbit carotid model

Francesco Prati, Marco Zimarino, Eugenio Stabile et al. · Heart · 2007 · 89 citations

Medicine, Bioengineering, Surgery +15